My analysis and intrinsic value of CHM March 2022, page-9

It's a biotech check out any number of other biotechs who have not made a cent and have a MC of $1b plus. It won't turn over $ for sometime and IMO will be bought out before then. When the institutions do decide to come in after a bit more data you want to be holding a good piece. The only reason some people create new threads like these is for blatant down ramping purposes. 3 years... Please. You clearly don't know this company. Those pretty little graphs on simply wall st cannot be used to analyse a company like this.